home / stock / silk / silk news


SILK News and Press, Silk Road Medical Inc. From 06/15/22

Stock Information

Company Name: Silk Road Medical Inc.
Stock Symbol: SILK
Market: NYSE
Website: silkroadmed.com

Menu

SILK SILK Quote SILK Short SILK News SILK Articles SILK Message Board
Get SILK Alerts

News, Short Squeeze, Breakout and More Instantly...

SILK - Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCAR

SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) --  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced a prospective study to evaluate the TCAR® system in the treatment of standard surgica...

SILK - Silk Road Medical Announces Expanded Medicare Coverage for TCAR in Standard Surgical Risk Patients

SUNNYVALE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society ...

SILK - Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing

SUNNYVALE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Company) (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has entered into a new five-year loan arrangement with Oxford Finance LLC (Oxford) compr...

SILK - Silk Road Medical, Inc 2022 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Silk Road Medical, Inc in conjunction with their 2022 Q1 earnings call. For further details see: Silk Road Medical, Inc 2022 Q1 - Results - Earnings Call Presentation

SILK - Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q1 2022 Results - Earnings Call Transcript

Silk Road Medical, Inc. (SILK) Q1 2022 Results Conference Call May 04, 2022 4:30 PM ET Company Participants Erica Rogers - CEO Lucas Buchanan - CFO Conference Call Participants Adam Maeder - Piper Sandler Danielle Antalffy - SVB Securities Javier Fonseca - Spartan Capital Rick Wise – S...

SILK - Silk Road Medical GAAP EPS of -$0.48 misses by $0.13, revenue of $2.8B beats by $2.77B

Silk Road Medical press release (NASDAQ:SILK): Q1 GAAP EPS of -$0.48 misses by $0.13. Revenue of $2.8B (+12569.7% Y/Y) beats by $2.77B. Cash and cash equivalents were $93.6 million as of March 31, 2022. For further details see: Silk Road Medical GAAP EPS of -$0.48 misses by $0.13, reven...

SILK - Silk Road Medical Reports First Quarter 2022 Financial Results

SUNNYVALE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2022. “We demonstrated strong execution...

SILK - ACCD, AFI and SEER among mid-day movers

Gainers: Redbox Entertainment (RDBX) +48%. Blue Apron Holdings (APRN) +36%. Accolade (ACCD) +28%. Forge Global Holdings (FRGE) +22%. Hilltop Holdings (HTH) +19%. The Oncology Institute (TOI) +18%. OppFi (OPFI) +18%. Seer (SEER) +16%. Companhia Energetica de Minas Gerais (CIG) +16%. Silk Road ...

SILK - Silk Road Medical, Clene top healthcare gainers; Global Cord Blood, Zosano lead losers' pack

Gainers: Silk Road Medical (SILK) +12%. Clene (CLNN) +6%. BioCardia (BCDA) +2%. Veru (VERU) +2%. ERYTECH Pharma (ERYP) +1%. Losers: Global Cord Blood (CO) -28%. Zosano Pharma (ZSAN) -21%. Vaxxinity (VAXX) -17%. HUTCHMED (China) (HCM)...

SILK - Silk Road Medical says FDA expanded approval for stent system

Medical device company, Silk Road Medical (NASDAQ:SILK) announced on Monday that the U.S. Food and Drug Administration (FDA) expanded the approval for its Enroute stent to include patients who are at standard risk for adverse events from carotid endarterectomy (CEA). Previously, the Enroute s...

Previous 10 Next 10